Progress in Primary Aldosteronism

M. Reincke; F. Beuschlein; M. Bidlingmaier; J. W. Funder; S. R. Bornstein

doi:10.1055/s-0030-1253417

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2010; 42(06): 371-373
DOI: 10.1055/s-0030-1253417

Editorial

Georg Thieme Verlag KG Stuttgart · New York

Progress in Primary Aldosteronism

M. Reincke

¹Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität München, München, Germany

,

F. Beuschlein

¹Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität München, München, Germany

,

M. Bidlingmaier

¹Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität München, München, Germany

,

J. W. Funder

²Prince Henry’s Institute of Medical Research, Monash Medical Centre, Clayton, Australia

,

S. R. Bornstein

³Department of Medicine III, Carl Gustav Carus University Hospital, Dresden, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM. Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281
2 Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res 2010; 42: 374-381
3 Quack I, Vonend O, Rump LC. Familial hyperaldosteronism I-III. Horm Metab Res 2010; 42: 424-428
4 Mazzuco TL, Grunenwald S, Lampron A, Bourdeau I, Lacroix A. Aberrant hormone receptors in primary aldosteronism. Horm Metab Res 2010; 42: 416-423
5 Bandulik S, Penton D, Barhanin J, Warth R. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation. Horm Metab Res 2010; 42: 450-457
6 Beuschlein F.. Animal models of primary aldosteronism. Horm Metab Res 2010; 42: 446-449
7 Tomaschitz A, Pilz S. Aldosterone to renin ratio – a reliable screening tool for primary aldosteronism?. Horm Metab Res 2010; 42: 382-391
8 Hannemann A, Friedrich N, Lüdemann J, Völzke H, Rettig R, Peters J, Reincke M, Döring A, Nauck M, Wallaschofski H. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based study of health in Pomerania (SHIP-1). Horm Metab Res 2010; 42: 392-399
9 Manolopoulou J, Gerum S, Mulatero P, Rossignol P, Plouin PF, Reincke M, Bidlingmaier M. Salivary aldosterone as a diagnostic aid in primary aldosteronism. Horm Metab Res 2010; 42: 400-405
10 Mulatero P, Monticone S, Bertello C, Mengozzi G, Tizzani D, Iannaccone A, Veglio F. Confirmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res 2010; 42: 406-410
11 Auchus RJ, Wians Jr FH, Anderson ME, Dolmatch BL, Trimmer CK, Josephs SC, Chan D, Toomay S, Nwariaku FE. What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res 2010; 42: 411-415
12 Quinkler M, Born-Frontsberg E, Fourkiotis VG. Comorbidities in primary aldosteronism. Horm Metab Res 2010; 42: 429-434
13 Schupp N, Queisser N, Wolf M, Kolkhof P, Bärfacker L, Schäfer S, Heidland A, Stopper H. Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists. Horm Metab Res 2010; 42: 458-465
14 Catena C, Colussi G, Di Fabio A, Valeri M, Marzano L, Uzzau A, Sechi LA.. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism. Horm Metab Res 2010; 42: 440-445
15 Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, Bidlingmaier M, Seissler J, Endres S. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn’s registry. Horm Metab Res 2010; 42: 435-439
16 Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 2003; 100: 14211-14216
17 Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, Haraguchi S, Emoto N, Okuno Y, Tsujimoto G, Kanematsu A, Ogawa O, Todo T, Tsutsui K, van der Horst GT, Okamura H. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010; 16: 67-74